Production Development
State-of-the-Art Life Sciences Research and Production Facility
General Capital developed a 133,000-square-foot, state-of-the-art life sciences research and production facility for Illumina within University Research Park in Madison, Wisconsin. Secured through a competitive selection process, the specialized build-to-suit development supports advanced enzyme manufacturing and the growing global demand for genetic sequencing products. The project required highly engineered building systems and precise coordination among architects, engineers, contractors, and consultants to accommodate Illumina's complex production requirements while maintaining flexibility for future operational needs.
Working collaboratively with Illumina and the City of Madison, General Capital assembled an experienced development team to deliver the mission-critical facility ahead of schedule and under budget. The project incorporates specialized manufacturing areas, laboratory space, and supporting offices designed to encourage collaboration and operational efficiency. Structured as a long-term investment with a triple-net lease guaranteed by Illumina, the development demonstrates General Capital's expertise in delivering complex life sciences facilities while supporting the continued growth of Madison's research and biotechnology sector.
Key Themes
- Specialized life sciences development supporting advanced genetic sequencing technologies.
- Competitive build-to-suit selection demonstrating technical expertise and development capabilities.
- Highly engineered facility accommodating complex enzyme manufacturing and research requirements.
- Public-private collaboration supporting development within Madison's University Research Park.
- Long-term investment strategy emphasizing tenant stability and future expansion flexibility.
Results
- 133,000 SF life sciences facility developed for Illumina in Madison.
- Ahead of schedule and under budget delivery of specialized manufacturing space.
- 15-year NNN lease secured with a global biotechnology leader.
- Advanced enzyme manufacturing capacity supporting worldwide genetic sequencing applications.
- Flexible laboratory and office space accommodating evolving operational requirements.